P

Pharmena SA
WSE:PHR

Watchlist Manager
Pharmena SA
WSE:PHR
Watchlist
Price: 3.99 PLN -1.97% Market Closed
Market Cap: zł44.4m

Operating Margin

-240%
Current
Declining
by 1 668.4%
vs 3-y average of 1 428.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-240%
=
Operating Income
zł-3.1m
/
Revenue
zł1.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-240%
=
Operating Income
zł-3.1m
/
Revenue
zł1.3m

Peer Comparison

Country Company Market Cap Operating
Margin
PL
Pharmena SA
WSE:PHR
45.3m PLN
Loading...
FR
L'Oreal SA
PAR:OR
204.9B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
118.9B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
34.2B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
42.4B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.4B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
920.5B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Lower than 92% of companies in Poland
Percentile
8th
Based on 835 companies
8th percentile
-240%
Low
-10 083 900% — -1.5%
Typical Range
-1.5% — 11.7%
High
11.7% — 195 905.3%
Distribution Statistics
Poland
Min -10 083 900%
30th Percentile -1.5%
Median 5.4%
70th Percentile 11.7%
Max 195 905.3%

Pharmena SA
Glance View

Market Cap
44.4m PLN
Industry
Consumer products

PHARMENA SA engages in developing and marketing products based on a patented, physiological, and natural active substance 1-MNA. The company is headquartered in Lodz, Woj. Lodzkie and currently employs 24 full-time employees. The company went IPO on 2008-08-25. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.

PHR Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-240%
=
Operating Income
zł-3.1m
/
Revenue
zł1.3m
What is Pharmena SA's current Operating Margin?

The current Operating Margin for Pharmena SA is -240%, which is below its 3-year median of 1 428.4%.

How has Operating Margin changed over time?

Over the last 3 years, Pharmena SA’s Operating Margin has decreased from -8.5% to -240%. During this period, it reached a low of -1 326.1% on Dec 31, 2022 and a high of 11 469.4% on Jun 30, 2024.

Back to Top